Protein / target
Neurofibromin
Protein at a glance
Biological role
Phosphatidylethanolamine binding
Strongest disease association
Neurofibromatosis 1
Research activity
Emerging research
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function overview
Stimulates the GTPase activity of Ras.
View complete UniProt function annotationHide complete annotation
Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity
Subcellular location
Domains and Gene Ontology detail (60)Hide
Domains & features
Gene Ontology
- Caxon
- Ccytoplasm
- Ccytosol
- Cdendrite
- Cglutamatergic synapse
- Cmembrane
- Cnucleolus
- Cnucleoplasm
- Cnucleus
- Cplasma membrane
- FGTPase activator activity
- Fphosphatidylcholine binding
Biological roles
What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.
View supporting evidenceHide supporting evidence
Synaptic signalling
- ·glutamatergic synapse
- ·regulation of postsynapse organization
Cell migration
- ·negative regulation of cell migration
- ·regulation of blood vessel endothelial cell migration
Apoptosis & cell death
- ·positive regulation of apoptotic process
- ·positive regulation of neuron apoptotic process
Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.
Translational evidence
Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.
Strongest disease associations · via encoding gene NF1
Gene-level evidence surfaced through the gene NF1that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.
View evidence synthesis (2)Hide
The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.
Show all associationsHide all associations
Tractability
Small molecules — Emerging
Antibodies — Emerging
Protein degraders — Emerging
View underlying tractability evidence (8)Hide
Raw Open Targets tractability assessment buckets, by modality.
Research activity
Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.
Most cited
Recent
Europe PMC papers linked directly to this protein.